On the recordOctober 29, 2019
I think transparency for us to understand that differential will help us know whether we are actually getting value.
Source
congress.govEditor's note · Context
Burgess advocates for transparency to assess the value of pharmaceutical costs.
Share
More from Michael Burgess
Jul 9, 2024
Last night, the Rules Committee met and reported out a rule, House Resolution 1341, providing for the consideration of five measures: H.R. 8281, Safeguard American Voter Eligibility Act; H.J. Res. 165, Providing for congressional…
Jul 9, 2024
Yes, I am. Are you prepared to take notes? Mr. McGOVERN. Okay. I will give you copies of what I am saying so you can have them. Madam Speaker, I yield myself the balance of my time to close. Madam Speaker, at the end of the day, it is not…
May 7, 2024
This is a national emergency. This is something we have got to address and save Americans, 200 every day.
Jun 26, 2024
Lives have been cut short by illegal immigrants on this administration's watch. We hear consistently about someone presenting to the border saying they have got credible fear if they return to their home country. They are granted asylum…
Other voices in this conversation
